2:09
Important stratifications for the treatment of ALL
Torsten Haferlach
1:17
The ALL frontier: should T-ALL be classed as a different disease?
Elizabeth Macintyre
1:54
Genome sequencing and transcription analysis: improving MM understanding
Nikhil Munshi
3:41
Computational methods are the future of biological research
Dominique Bonnet
4:42
Non-invasive bone marrow screening to detect early leukemic cells
Dominique Bonnet
9:26
Understanding the evolution from haematopoietic stem cell to leukemic cell
Dominique Bonnet
1:53
The future of leukemia treatment leans towards immunotherapy
Robin Foà
2:25
Novel revelations in CLL biology with venetoclax/ibrutinib
Arnon Kater
1:06
Response to MM therapy can vary based on a variety of factors
Shaji Kumar
2:04
Restarting the apoptotic pathway in myeloma cells
Shaji Kumar
3:29
New abstracts outline how MM cleverly evades immune detection
Fabio Malavasi
4:28
Advances in the classification of agressive myeloma
Nikhil Munshi
3:16
AML metabolism may be the key to successful treatment
Giovanni Martinelli
4:52
WGS: advancing Waldenström’s diagnosis, prognosis & treatment
Steven Treon
1:11
Unmet needs in Waldenström’s macroglobulinemia
Steven Treon
2:36
Novel therapeutic options for Waldenström’s macroglobulinemia
Steven Treon
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals